ASU Diagnostics Roundtable — The Future of Testing in Turbulent Times
Event description
- Free
- Health and wellness
- Open to the public
- Science
The ASU Diagnostics Roundtable: The Future of Testing in Turbulent Times brings together experts from academia, industry and government in Washington, D.C., to address the current issues and opportunities in diagnostics.
Join us to hear from experts discussing:
- Congressional legislation likely to impact the diagnostics industry.
- New testing technologies.
- The future workforce of diagnostics.
- Leadership of diagnostic companies today.
This event offers an opportunity for networking, meaningful discussion and actionable takeaways, and is available at no cost with lunch provided.
Keynote speaker
Jeff Shuren
Former director
FDA Center for Devices and Radiological Health
Agenda
| 8:15 a.m. | Registration, networking and breakfast |
| 9 a.m. | Welcome remarks Matt Hulver, VP of Knowledge Enterprise Initiatives |
| 9:05 a.m. | Keynote speaker Dr. Jeffrey Shuren Jeffrey Shuren was the director of the Center for Devices and Radiological Health at the United States Food and Drug Administration from September 2009 to July 2024. Shuren was responsible for the development of Medicare national coverage determinations for drugs, biologics and non-implantable devices, while director of the Division of Items and Devices, Coverage and Analysis Group at the Centers for Medicare and Medicaid Services. |
| 9:35 a.m. | Fireside chat with David Steury Moderator: Amy Kelbick, McDermott+ David Steury, health policy director, Office of Congresswoman Diana DeGette (D-CO) Steury will discuss Rep. Diana DeGette’s signature legislation, the 21st Century CURES Act, and plans for Cures 2.0. Both of these bills aim to speed development and coverage of novel health care treatments, including diagnostics. Steury will also speak about the current work of the U.S. House Committee on Energy and Commerce Subcommittee on Health. |
| 9:55 a.m. | Diagnostics Policy Issues: Looking Forward Moderator: Ralph Hall, Hall Strategies Panelists: This session will address the discussion from the prior session, highlighting the current and potential future state of diagnostics-related issues and the impact of federal policies on the testing landscape including Laboratory Developed Tests regulation, reimbursement hurdles and opportunities for innovation in diagnostics. They will also discuss examples of successful strategies and how stakeholders can collaborate to shape policy. |
| 10:50 a.m. | Break |
| 11 a.m. | Expanding the Reach of Diagnostics Moderator: Amit Agrawal, Danaher Panelists: This session will explore the progress of new technologies (AI, digital health, including proteomics and spatialomics, etc.) not only in driving precision medicine forward and expanding access to testing but even influencing epidemiological characteristics of patient populations. What other vectors can expand the reach of diagnostics? What still needs to be accomplished to fully realize the benefits of testing access for all, improved diagnostic accuracy, patient compliance and cost efficiencies? Challenges such as data interoperability, awareness and reimbursement as well as proposed solutions for each challenge will be highlighted. |
| Noon | Leadership in Times of Uncertainty Moderator: Michael Yudell, ASU Panelists: Our CEO panelists will discuss how they lead their companies in complex times (and in diagnostics – it is always complex)! They will share their wisdom in guiding and building resilient teams and providing clarity at times of change. They will share the lessons they have learned, in creating cultures of inclusive excellence, staying grounded yet adaptive to change and making good decisions under pressure. |
| 1 p.m. | The Diagnostics Workforce of Tomorrow Moderator: Michael Donovan, ASU Panelists: This session will focus on how leading companies build and retain the highest-quality teams to meet their current and future business demands. They will discuss the impact of new technologies including AI and automation and the importance of employers staying in tune with these trends. Panel will discuss current talent shortages, as well as best practices in recruitment, retention, training and leadership development. Labcorp and InStride will share their recently announced workforce development model as one example of innovating to maximize human resource potential and train the next generation in labs worldwide. |
| 1:45 p.m. | Year in review and next steps Mara Aspinall, partner, Illumina Ventures; and professor of practice, ASU The last year was an active one for the diagnostics industry, marked by regulatory shifts, technological advances and select investment rebounds. Many hurdles and uncertainties remain, particularly in the areas of reimbursement, the utility of AI and regulatory processes. However, the sector’s growth opportunities are promising. Diagnostics are playing an increasingly central role in precision medicine, home health care and AI-driven clinical decision-making. During this session, Aspinall will highlight the financial and investment landscape, regulatory and reimbursement developments, market and technology evolution, and hurdles and opportunities for future growth. |